Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025)
Xtant Medical Holdings (XTNT) reported Asset Writedowns and Impairment of $828000.0 for Q3 2025, up 1527.59% year-over-year from $50872.9 in Q3 2024, and up 1723.53% quarter-over-quarter from -$51000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 9 years of Asset Writedowns and Impairment data on file, last reported at $828000.0 in Q3 2025.
- Asset Writedowns and Impairment for Q3 2025 came in at $828000.0, up 1527.59% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.5 million (up 409.69% YoY), and the FY2024 annual result was $485000.0, up 35.85% from the prior year.
- Asset Writedowns and Impairment rose to $828000.0 in Q3 2025 per XTNT's latest filing, from -$51000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.4 million in Q3 2022 and troughed at -$58000.0 in Q3 2024.
- A 5-year average of $248684.2 and a median of $153000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2021 and 2025: Asset Writedowns and Impairment soared 2327.27% in 2021, then slumped 139.53% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $267000.0 in 2021, then decreased by 8.61% to $244000.0 in 2022, then plunged by 116.8% to -$41000.0 in 2023, then surged by 478.05% to $155000.0 in 2024, then jumped by 434.19% to $828000.0 in 2025.
- Business Quant data shows XTNT's Asset Writedowns and Impairment at $828000.0 in Q3 2025, -$51000.0 in Q2 2025, and $541000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 828,000.00 |
| Sep 30, 2025 | 828,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 153,000.00 |